Development of Federally Mandated Risk Evaluation and Mitigation Strategies (REMS) for Transmucosal Immediate-Release Fentanyl Products

Detalles Bibliográficos
Autores principales: Pergolizzi, Joseph V, Gharibo, Christopher G, Gudin, Jeffrey A, Nalamachu, Srinivas R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2013
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3666085/
https://www.ncbi.nlm.nih.gov/pubmed/23464790
http://dx.doi.org/10.1111/papr.12040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3666085/
https://www.ncbi.nlm.nih.gov/pubmed/23464790
http://dx.doi.org/10.1111/papr.12040

Ejemplares similares